Improvement of cardiac performance by intravenous infusion of L-arginine in patients with moderate congestive heart failure

Department of Cardiology, Tel Aviv Medical Center, Tel Aviv University, Israel.

OBJECTIVES. The aim of this study was to evaluate the hemodynamic effect of L-arginine infusion in patients with congestive heart failure. BACKGROUND. Endothelium-dependent vasodilation is impaired in patients with congestive heart failure. Nitric oxide, which was identified as endothelium-derived relaxing factor, is generated by nitric oxide synthase from L-arginine. Our hypothesis was that administration of L-arginine in patients with congestive heart failure may increase nitric oxide production and have a beneficial hemodynamic effect. METHODS. Twelve patients with congestive heart failure (New York Heart Association class II or III) due to coronary artery disease (left ventricular ejection fraction < 35%) were given 20 g of L-arginine by intravenous infusion over 1 h at a constant rate. Stroke volume, cardiac output and left ventricular ejection fraction were determined with Doppler echocardiography at baseline and at 30 and 60 min and 1 h after the end of infusion. Blood and urinary levels of nitrite/nitrate (NO2/NO3), stable metabolites of nitric oxide, were measured and clearance was calculated. RESULTS. One hour of infusion of L-arginine resulted in a significant increase in stroke volume (from 68 +/- 18 ml to 76 +/- 23 ml [mean +/- SD], p = 0.014) and cardiac output (from 4.07 +/- 1.22 liters/min to 4.7 +/- 1.42 liters/min, p = 0.006) without a change in heart rate. Mean arterial blood pressure decreased (from 102 +/- 11 mm Hg to 89 +/- 9.5 mm Hg, p < 0.002), and systemic vascular resistance decreased significantly. Within 1 h after cessation of L-arginine infusion, blood pressure, stroke volume, cardiac output and systemic vascular resistance were statistically not different from baseline values. Clearance of NO2/NO3 increased significantly during L-arginine administration (from 13.28 +/- 0.42 ml/min to 29.97 +/- 1.09 ml/min, p < 0.001). CONCLUSIONS. Infusion of L-arginine in patients with congestive heart failure results in increased production of nitric oxide, peripheral vasodilation and increased cardiac output, suggesting a beneficial hemodynamic and possibly therapeutic profile.

This article has been cited by other articles:

				E. N. Dedkova and L. A. Blatter Characteristics and function of cardiac mitochondrial nitric oxide synthase J. Physiol., February 15, 2009; 587(4): 851 - 872. [Abstract] [Full Text] [PDF]

				R. D. Peluffo L-Arginine currents in rat cardiac ventricular myocytes J. Physiol., May 1, 2007; 580(3): 925 - 936. [Abstract] [Full Text] [PDF]

				C. V. Remillard and J. X.-J. Yuan Cardiac L-arginine transport: the CAT is back J. Physiol., May 1, 2007; 580(3): 699 - 700. [Full Text] [PDF]

				N. NAGAYA, M. UEMATSU, H. OYA, N. SATO, F. SAKAMAKI, S. KYOTANI, K. UENO, N. NAKANISHI, M. YAMAGISHI, and K. MIYATAKE Short-term Oral Administration of L-Arginine Improves Hemodynamics and Exercise Capacity in Patients with Precapillary Pulmonary Hypertension Am. J. Respir. Crit. Care Med., March 15, 2001; 163(4): 887 - 891. [Abstract] [Full Text]

				A.C. Mendes Ribeiro, T.M.C. Brunini, J.C. Ellory, and G.E. Mann Abnormalities in L-arginine transport and nitric oxide biosynthesis in chronic renal and heart failure Cardiovasc Res, March 1, 2001; 49(4): 697 - 712. [Abstract] [Full Text] [PDF]

				S. Greenberg, G. Chemin, I. Shapira, J. George, Y. Wollman, S. Laniado, and G. Keren Captopril and L-Arginine Have a Synergistic Cardioprotective Effect in Ischemic-Reperfusion Injury in the Isolated Rat Heart Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2000; 5(4): 281 - 290. [Abstract] [PDF]

				A. P. Banning and B. Prendergast Intravenous L-arginine reduces VE/VCO2 slope acutely in patients with severe chronic heart failure Eur J Heart Fail, June 1, 1999; 1(2): 187 - 190. [Full Text] [PDF]

				Y Kanaya, M Nakamura, N Kobayashi, and K Hiramori Effects of L-arginine on lower limb vasodilator reserve and exercise capacity in patients with chronic heart failure Heart, May 1, 1999; 81(5): 512 - 517. [Abstract] [Full Text]

				N. Dakak, S. Husain, D. Mulcahy, N. P. Andrews, J. A. Panza, M. Waclawiw, W. Schenke, and A. A. Quyyumi Contribution of Nitric Oxide to Reactive Hyperemia : Impact of Endothelial Dysfunction Hypertension, July 1, 1998; 32(1): 9 - 15. [Abstract] [Full Text] [PDF]

				L-Arginine Improves Cardiac Performance in CHF Journal Watch Cardiology, January 1, 1996; 1996(101): 9 - 9. [Full Text]